This subject will introduce students to bacterial and eukaryotic genetics. This will be followed by in depth study of genetic engineering and related innovative applications in modern medical biotechnology. A short introduction into bioinformatics will be provided as well.
No offerings have been identified for this subject in 2019.
School of Biomedical Sciences
Master of Corporate Biotechnology students only
* Genomes (viral, prokaryotic, eukaryotic and human); * Genetic analysis of prokaryotes; * Genetics of eukaryotes; * tools of genetic manipulation I: restriction endonucleases, methylases, nucleases, polymerases, ribonucleases, exonucleases, transcriptases, ligases, kinases. Uses of primers, adaptors, linkers; * Tools of Genetic Manipulation II: DNA (Phosphite triester) and Peptide Synthesis, protein engineering, oligonucleotides, peptide pharmaceuticals and automated synthesis. In vitro mutagenesis and elucidation of gene function; * strategies for gene isolation: cloning DNA libraries and genomic DNA libraries, screening for genes of interest; * expression engineering and gearing up of production; * application of biotechnology: human germ-line and somatic gene therapy; transgenic livestock for industry; transgenic animals as pharmaceutical factories; peptide vaccines, peptide pharmaceuticals, vaccinia viruses, antibiotics, recombinant vaccines, food and beverage improvement;. * introduction to regulating and patenting molecular biotechnology
For any enquiries about subject selection or course structure please contact Student Central or firstname.lastname@example.org or phone on 1800 275 278.
For further information about Charles Sturt University, or this course offering, please contact info.csu on 1800 334 733 (free call within Australia) or enquire online.
The information contained in the 2019 CSU Handbook was accurate at the date of publication: September 2018. The University reserves the right to vary the information at any time without notice.